BR9915270A - Método para prevenir e reverter aterosclerose em mamìferos - Google Patents
Método para prevenir e reverter aterosclerose em mamìferosInfo
- Publication number
- BR9915270A BR9915270A BR9915270-3A BR9915270A BR9915270A BR 9915270 A BR9915270 A BR 9915270A BR 9915270 A BR9915270 A BR 9915270A BR 9915270 A BR9915270 A BR 9915270A
- Authority
- BR
- Brazil
- Prior art keywords
- aliquot
- mammal
- mammals
- prevent
- atherosclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
"MéTODO PARA PREVENIR E REVERTER ATEROSCLEROSE EM MAMìFEROS". Um método para prevenir a progressão e para causar a regressão de aterosclerose em um mamífero compreende: (a) tratar uma porção de sangue de mamífero ex vivo com pelo menos um elemento causador de temperatura selecionado do grupo que consiste em uma temperatura acima ou abaixo da temperatura corpórea, uma emissão eletromagnética e um ambiente oxidativo; e (b) administrar a porção de sangue tratado na etapa (a) ao mamífero, onde a porção possui um volume suficiente para alcançar uma regressão em uma lesão de aterosclerose existente no mamífero.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19023698A | 1998-11-13 | 1998-11-13 | |
US09/304,262 US6264646B1 (en) | 1998-11-13 | 1999-05-06 | Method for preventing and reversing atherosclerosis in mammals |
PCT/CA1999/001092 WO2000029003A2 (en) | 1998-11-13 | 1999-11-15 | Method for preventing and reversing atherosclerosis in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915270A true BR9915270A (pt) | 2003-12-30 |
Family
ID=26885899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915270-3A BR9915270A (pt) | 1998-11-13 | 1999-11-15 | Método para prevenir e reverter aterosclerose em mamìferos |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1128837B1 (pt) |
JP (1) | JP2002529510A (pt) |
CN (1) | CN1230182C (pt) |
AT (1) | ATE233093T1 (pt) |
AU (1) | AU768300B2 (pt) |
BR (1) | BR9915270A (pt) |
CA (1) | CA2348599A1 (pt) |
CZ (1) | CZ20011642A3 (pt) |
DE (1) | DE69905602T2 (pt) |
DK (1) | DK1128837T3 (pt) |
EA (1) | EA003421B1 (pt) |
ES (1) | ES2192885T3 (pt) |
MX (1) | MXPA01004801A (pt) |
NO (1) | NO20012311L (pt) |
NZ (1) | NZ511467A (pt) |
WO (1) | WO2000029003A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2271190A1 (en) | 1999-05-06 | 2000-11-06 | Vasogen Ireland Limited | Improved method for treating mammals with modified mammalian blood |
US7125897B1 (en) | 1999-09-24 | 2006-10-24 | Vasogen Ireland Limited | Combined therapies for atherosclerosis treatment |
CA2309417A1 (en) * | 2000-05-25 | 2001-11-25 | Anthony E. Bolton | Apoptotic entities for use in treatment of endothelium dysfunction disorders |
WO2005097145A1 (en) * | 2004-04-12 | 2005-10-20 | Vasogen Ireland Limited | Myocarditis treatment |
WO2008000067A1 (en) * | 2006-06-26 | 2008-01-03 | Vasogen Ireland Limited | Treatment of mild chronic heart failure in human patients |
RU2475275C1 (ru) * | 2011-08-08 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
RU2475274C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения атеросклероза артерий нижних конечностей |
RU2475276C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD249143A3 (de) * | 1985-03-20 | 1987-09-02 | Ilmenau Tech Hochschule | Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes |
WO1993015778A1 (en) * | 1992-02-07 | 1993-08-19 | Anthony Ernest Bolton | Method of inhibiting the aggregation of blood platelets |
US5980954A (en) * | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
-
1999
- 1999-11-15 MX MXPA01004801A patent/MXPA01004801A/es not_active IP Right Cessation
- 1999-11-15 EP EP99972104A patent/EP1128837B1/en not_active Expired - Lifetime
- 1999-11-15 DK DK99972104T patent/DK1128837T3/da active
- 1999-11-15 NZ NZ511467A patent/NZ511467A/xx not_active IP Right Cessation
- 1999-11-15 EA EA200100543A patent/EA003421B1/ru not_active IP Right Cessation
- 1999-11-15 WO PCT/CA1999/001092 patent/WO2000029003A2/en active IP Right Grant
- 1999-11-15 CZ CZ20011642A patent/CZ20011642A3/cs unknown
- 1999-11-15 DE DE69905602T patent/DE69905602T2/de not_active Expired - Lifetime
- 1999-11-15 CA CA002348599A patent/CA2348599A1/en not_active Abandoned
- 1999-11-15 AT AT99972104T patent/ATE233093T1/de not_active IP Right Cessation
- 1999-11-15 BR BR9915270-3A patent/BR9915270A/pt not_active Application Discontinuation
- 1999-11-15 JP JP2000582049A patent/JP2002529510A/ja not_active Withdrawn
- 1999-11-15 ES ES99972104T patent/ES2192885T3/es not_active Expired - Lifetime
- 1999-11-15 CN CNB998146390A patent/CN1230182C/zh not_active Expired - Fee Related
- 1999-11-15 AU AU11450/00A patent/AU768300B2/en not_active Ceased
-
2001
- 2001-05-10 NO NO20012311A patent/NO20012311L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000029003A2 (en) | 2000-05-25 |
EA003421B1 (ru) | 2003-04-24 |
NO20012311L (no) | 2001-07-02 |
EP1128837A2 (en) | 2001-09-05 |
WO2000029003A3 (en) | 2000-08-31 |
AU1145000A (en) | 2000-06-05 |
EA200100543A1 (ru) | 2001-10-22 |
ES2192885T3 (es) | 2003-10-16 |
DE69905602T2 (de) | 2003-10-09 |
DK1128837T3 (da) | 2003-06-16 |
AU768300B2 (en) | 2003-12-04 |
EP1128837B1 (en) | 2003-02-26 |
CA2348599A1 (en) | 2000-05-25 |
JP2002529510A (ja) | 2002-09-10 |
ATE233093T1 (de) | 2003-03-15 |
DE69905602D1 (de) | 2003-04-03 |
NZ511467A (en) | 2002-12-20 |
CZ20011642A3 (cs) | 2002-06-12 |
CN1230182C (zh) | 2005-12-07 |
MXPA01004801A (es) | 2002-09-18 |
CN1330549A (zh) | 2002-01-09 |
NO20012311D0 (no) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69923671D1 (de) | Verwendung von kannabidiol als entzündunghemmende mittel | |
ES2192642T3 (es) | Producto para el teñido oxidante de fibras de queratina.. | |
EA199800667A1 (ru) | Новые фенантридины | |
IT8519212A0 (it) | Riduzione di una lesione arteriosclerotica mediante assorbimento selettivo di energia elettromagnetica in un suo componente. | |
TR200201822T2 (tr) | Konjestif kalp yetmezliğinin ön-tedavi görmüş otolog kan ile tedavi edilmesi. | |
ES2159309T3 (es) | Semillas tratadas. | |
HN1996000017A (es) | Isotiazolonas | |
BR9915270A (pt) | Método para prevenir e reverter aterosclerose em mamìferos | |
NL1004205A1 (nl) | Microgolf oven met verbeterde deur. | |
UA37199C2 (uk) | Алкіламінокетони | |
PT1092040E (pt) | Metodos de inibicao helicobacter pylori | |
TR199900430T2 (xx) | �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar. | |
SE9803079D0 (sv) | Sätt och anordning vid värmebehandling av kroppsvävnad | |
DE69840575D1 (de) | Optischer wellenleiter mit mikrospiegel, sein herstellungsverfahren, und optischer signalprozessor | |
BR9304873A (pt) | Método para aperfeiçoar um processo enzimático, utilizando pelo menos uma enzima que apresenta atividade pectinase. | |
ID28174A (id) | Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya | |
DE3864011D1 (de) | Scheibenkupplung. | |
DE60314123D1 (de) | Selektive oxidation mit erhöhter sicherheit | |
PT1017377E (pt) | Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina | |
Wolters | Heat treatment of lamellar and spheroidal graphite cast iron. II | |
UA43400C2 (uk) | Спосіб підсилення рівня електричного сигналу | |
ES1027848Y (es) | Pestillo con palanca de traccion. | |
UA30521A (uk) | Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом | |
IT1274939B (it) | Serratura di sicurezza a funzionamento elettrico e manuale | |
ECSP961804A (es) | Nuevos compuestos monociclicos de b -.lactama |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 10 (VIII) DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |